332 related articles for article (PubMed ID: 27196477)
21. Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
Li FY; Wu SG; Zhou J; Sun JY; Lin Q; Lin HX; Guan XX; He ZY
PLoS One; 2014; 9(2):e87264. PubMed ID: 24498305
[TBL] [Abstract][Full Text] [Related]
22. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
[TBL] [Abstract][Full Text] [Related]
23. Breast Cancer Subtype is Associated With Axillary Lymph Node Metastasis: A Retrospective Cohort Study.
He ZY; Wu SG; Yang Q; Sun JY; Li FY; Lin Q; Lin HX
Medicine (Baltimore); 2015 Dec; 94(48):e2213. PubMed ID: 26632910
[TBL] [Abstract][Full Text] [Related]
24. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
25. Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes.
Khande TA; Joshi AR; Khandeparkar SGS; Kulkarni MM; Gogate BP; Kakade AR; Sahu PD; Khillare CD
Indian J Cancer; 2020; 57(2):190-197. PubMed ID: 32445323
[TBL] [Abstract][Full Text] [Related]
26. Correlation of Conventional Ultrasound Characteristics of Breast Tumors With Axillary Lymph Node Metastasis and Ki-67 Expression in Patients With Breast Cancer.
Zhang H; Sui X; Zhou S; Hu L; Huang X
J Ultrasound Med; 2019 Jul; 38(7):1833-1840. PubMed ID: 30480840
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
28. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
[No Abstract] [Full Text] [Related]
29. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
[TBL] [Abstract][Full Text] [Related]
31. Association between molecular subtypes and lymph node status in invasive breast cancer.
Si C; Jin Y; Wang H; Zou Q
Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761
[TBL] [Abstract][Full Text] [Related]
32. Role of axillary node dissection in patients with T1a and T1b breast cancer: Mayo Clinic experience.
Mincey BA; Bammer T; Atkinson EJ; Perez EA
Arch Surg; 2001 Jul; 136(7):779-82. PubMed ID: 11448390
[TBL] [Abstract][Full Text] [Related]
33. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
[TBL] [Abstract][Full Text] [Related]
34. Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients.
De Santis MC; La Rocca E; Meneghini E; Bregni G; Di Lorenzo G; Galli G; Di Nicola M; Folli S; Gennaro M; Pruneri G; Paolini B; Daidone MG; De Braud F; Apolone G; Sant M; Di Cosimo S
Clin Transl Oncol; 2020 May; 22(5):786-792. PubMed ID: 31372896
[TBL] [Abstract][Full Text] [Related]
35. Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors.
González-Vela MC; Garijo MF; Fernández FA; Buelta L; Val-Bernal JF
Pathol Res Pract; 1999; 195(9):611-8. PubMed ID: 10507081
[TBL] [Abstract][Full Text] [Related]
36. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
37. Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age.
Orucevic A; Reddy VB; Bloom KJ; Bitterman P; Magi-Galluzzi C; Oleske DM; Phillips M; Gould VE; Cobleigh M; Wick MR; Gattuso P
Breast J; 2002; 8(6):349-55. PubMed ID: 12390357
[TBL] [Abstract][Full Text] [Related]
38. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
39. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
[No Abstract] [Full Text] [Related]
40. Predicting axillary nodal positivity in 2282 patients with breast carcinoma.
Silverstein MJ; Skinner KA; Lomis TJ
World J Surg; 2001 Jun; 25(6):767-72. PubMed ID: 11376414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
